131890-57-8

Basic information

• Product Name: 8-(4-methylphenyI)-6-oxo-2H,3H,4H,6H-pyrimido[2,1-b][1,3]thiazine-7-carbonitrile
• Synonyms: 8-(4-methylphenyI)-6-oxo-2H,3H,4H,6H-pyrimido[2,1-b][1,3]thiazine-7-carbonitrile
• CAS NO: 131890-57-8
• Molecular Weight: 283.354
• Mol File: 131890-57-8.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: 8-(4-methylphenyI)-6-oxo-2H,3H,4H,6H-pyrimido[2,1-b][1,3]thiazine-7-carbonitrile(CAS DataBase Reference)
• NIST Chemistry Reference: 8-(4-methylphenyI)-6-oxo-2H,3H,4H,6H-pyrimido[2,1-b][1,3]thiazine-7-carbonitrile(131890-57-8)
• EPA Substance Registry System: 8-(4-methylphenyI)-6-oxo-2H,3H,4H,6H-pyrimido[2,1-b][1,3]thiazine-7-carbonitrile(131890-57-8)

Safety Data

• Hazardous Substances Data: 131890-57-8(Hazardous Substances Data)

Upstream product

• 109-64-8 1,3-dibromo-propane 
• 70638-53-8 4‐oxo‐2‐thioxo‐6‐(p-tolyl)‐1,2,3,4‐tetrahydropyrimidine‐5‐carbonitrile 

Relevant articles and documents

NMDA RECEPTOR MODULATORS AND USES THEREOF

Disclosed herein, in part, are heteroaromatic compounds and methods of use in treating neuropsychiatric disorders, e.g., schizophrenia and major depressive disorder. Pharmaceutical compositions and methods of making heteroaromatic compounds are provided. The compounds are contemplated to modulate the NMDA receptor.

Chemotherapeutic agents: Part XX. Antileishmanial and immunoadjuvant activities of rationally designed thiopyrimidines

-